Lascoux-Combe C - Search Results

1

Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV-1 infected patients in 2020-2023.

Chaix ML, Terracol L, Nere ML, Stefic K, Lascoux-Combe C, Manda V, Sellier P, Maylin S, Molina JM, Liegeon G, Delaugerre C, Salmona M. Chaix ML, et al. Among authors: lascoux combe c. J Med Virol. 2024 Oct;96(10):e29948. doi: 10.1002/jmv.29948. J Med Virol. 2024. PMID: 39363782

2

Characterization of HIV-1 diversity in various compartments at the time of primary infection by ultradeep sequencing.

Gaube G, Armero A, Salmona M, Néré ML, Mahjoub N, Lascoux-Combe C, Gabassi A, Gallien S, Amara A, Molina JM, Delaugerre C, Chaix ML. Gaube G, et al. Sci Rep. 2020 Feb 12;10(1):2409. doi: 10.1038/s41598-020-59234-6. Sci Rep. 2020. PMID: 32051463 Free PMC article.

3

HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 Infection.

Ghosn J, Assoumou L, Lascoux-Combe C, Peytavin G, Amat K, Gabassi A, Le MP, Nzalakanda R, Valin N, Landman R, Chaix ML, Delaugerre C. Ghosn J, et al. J Infect Dis. 2022 Jan 5;225(1):116-120. doi: 10.1093/infdis/jiab336. J Infect Dis. 2022. PMID: 34166492

4

Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B.

Dezanet LNC, Miailhes P, Lascoux-Combe C, Chas J, Maylin S, Gabassi A, Rougier H, Delaugerre C, Lacombe K, Boyd A. Dezanet LNC, et al. Liver Int. 2021 Dec;41(12):2874-2884. doi: 10.1111/liv.15019. Epub 2021 Jul 30. Liver Int. 2021. PMID: 34297463

5

Transmission of S230R integrase drug resistance mutation affecting second-generation integrase inhibitors in a French primary HIV-1 infected man.

Salmona M, Lascoux-Combe C, Nere ML, Rubenstein E, Molina JM, Delaugerre C, Chaix ML. Salmona M, et al. Among authors: lascoux combe c. J Antimicrob Chemother. 2023 Jul 5;78(7):1802-1803. doi: 10.1093/jac/dkad135. J Antimicrob Chemother. 2023. PMID: 37147875 No abstract available.

6

Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine.

Rubenstein E, Diemer M, Goldwirt L, Lascoux-Combe C, Chaix ML, Rami A, Ponscarme D, Lafaurie M, Denis B, De Castro N, Gras J, Liegeon G, Sellier PO, Deville L, Chevret S, Delaugerre C, Molina JM. Rubenstein E, et al. Among authors: lascoux combe c. AIDS. 2024 Jul 1;38(8):1267-1269. doi: 10.1097/QAD.0000000000003887. Epub 2024 May 30. AIDS. 2024. PMID: 38814715

7

Does the ultrasensitive HBsAg Next assay enhance Hepatitis B diagnosis? An evaluation of analytical performances.

Bourdin J, Sellier P, Salmona M, Lascoux-Combe C, Delaugerre C, Maylin S. Bourdin J, et al. Among authors: lascoux combe c. J Clin Virol. 2024 Oct;174:105707. doi: 10.1016/j.jcv.2024.105707. Epub 2024 Jun 22. J Clin Virol. 2024. PMID: 38964144

8

High concentration of raltegravir in semen of HIV-infected men: results from a substudy of the EASIER-ANRS 138 trial.

Barau C, Delaugerre C, Braun J, de Castro N, Furlan V, Charreau I, Gérard L, Lascoux-Combe C, Molina JM, Taburet AM. Barau C, et al. Antimicrob Agents Chemother. 2010 Feb;54(2):937-9. doi: 10.1128/AAC.01261-09. Epub 2009 Dec 7. Antimicrob Agents Chemother. 2010. PMID: 19995925 Free PMC article. Clinical Trial.

9

Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients.

Maylin S, Boyd A, Lavocat F, Gozlan J, Lascoux-Combe C, Miailhes P, Lassel L, Delaugerre C, Girard PM, Zoulim F, Lacombe K. Maylin S, et al. AIDS. 2012 May 15;26(8):939-49. doi: 10.1097/QAD.0b013e328352224d. AIDS. 2012. PMID: 22333748

10

Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.

Lortholary O, Roussillon C, Boucherie C, Padoin C, Chaix ML, Breton G, Rami A, Veziris N, Patey O, Caumes E, May T, Molina JM, Robert J, Tod M, Fagard C, Chêne G; ANRS 129 BKVIR Trial Group. Lortholary O, et al. J Antimicrob Chemother. 2016 Mar;71(3):783-93. doi: 10.1093/jac/dkv384. Epub 2015 Dec 17. J Antimicrob Chemother. 2016. PMID: 26679250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters